Glen Eagle Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469 | Hold |
50
| – | – | ﹤0.01% | 985 |
|
|
2025
Q1 | $356 | Hold |
50
| – | – | ﹤0.01% | 1014 |
|
|
2024
Q4 | $583 | Hold |
50
| – | – | ﹤0.01% | 1017 |
|
|
2024
Q3 | $1.03K | Hold |
50
| – | – | ﹤0.01% | 1000 |
|
|
2024
Q2 | $1.12K | Hold |
50
| – | – | ﹤0.01% | 981 |
|
|
2024
Q1 | $1.38K | Hold |
50
| – | – | ﹤0.01% | 955 |
|
|
2023
Q4 | $1.53K | Hold |
50
| – | – | ﹤0.01% | 894 |
|
|
2023
Q3 | $1.58K | Hold |
50
| – | – | ﹤0.01% | 891 |
|
|
2023
Q2 | $2.04K | Hold |
50
| – | – | ﹤0.01% | 872 |
|
|
2023
Q1 | $1.86K | Buy |
+50
| New | +$1.86K | ﹤0.01% | 861 |
|
|
2022
Q1 | – | Sell |
-62
| Closed | -$7.33K | – | 967 |
|
|
2021
Q4 | $7.33K | Sell |
62
-85
| -58% | -$10.1K | ﹤0.01% | 666 |
|
|
2021
Q3 | $19.7K | Buy |
147
+12
| +9% | +$1.61K | 0.01% | 561 |
|
|
2021
Q2 | $21.9K | Sell |
135
-190
| -58% | -$30.8K | 0.01% | 541 |
|
|
2021
Q1 | $26.1K | Hold |
325
| – | – | 0.01% | 465 |
|
|
2020
Q4 | $17.7K | Hold |
325
| – | – | 0.01% | 521 |
|
|
2020
Q3 | $6.46K | Hold |
325
| – | – | ﹤0.01% | 663 |
|
|
2020
Q2 | $6.83K | Buy |
+325
| New | +$6.83K | ﹤0.01% | 624 |
|